{"transactions":[{"id":1109343,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":78426,"kind":"person","name":"Martin Anne-Marie","position":1,"cik":"0001914495","reported_name":"Martin Anne-Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-16T20:07:18.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":38513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date"}],"balance_after":38513,"derivative":{"exercise_price":8.95,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":38513},"source":{"system":"sec-edgar","filing":"0000950170-25-086718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017025086718/ownership.xml","form_type":"4"}},{"id":1467913,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":78426,"kind":"person","name":"Martin Anne-Marie","position":1,"cik":"0001914495","reported_name":"Martin Anne-Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T23:00:04.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":15806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 15,806 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 26, 2025 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date."}],"balance_after":15806,"derivative":{"exercise_price":16.5,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":15806},"source":{"system":"sec-edgar","filing":"0000950170-24-078676","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017024078676/ownership.xml","form_type":"4"}},{"id":1858186,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":78426,"kind":"person","name":"Martin Anne-Marie","position":1,"cik":"0001914495","reported_name":"Martin Anne-Marie","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T21:50:55.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":18450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 18,450 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 8, 2024 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date."}],"balance_after":18450,"derivative":{"exercise_price":13,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":18450},"source":{"system":"sec-edgar","filing":"0000950170-23-027537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000095017023027537/ownership.xml","form_type":"4"}},{"id":2359197,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":78426,"kind":"person","name":"Martin Anne-Marie","position":1,"cik":"0001914495","reported_name":"Martin Anne-Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T00:05:23.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":36880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 36,880 shares of the Issuer's Common Stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date."}],"balance_after":36880,"derivative":{"exercise_price":13.99,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":36880},"source":{"system":"sec-edgar","filing":"0000899243-22-008729","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789972/000089924322008729/doc4.xml","form_type":"4"}}]}